Genzyme Accuses Shire Of Making False Bone Drug Claims

Law360, New York (July 30, 2012, 7:32 PM EDT) -- Sanofi SA subsidiary Genzyme Corp. filed a lawsuit Monday in Massachusetts accusing rival Shire Human Genetic Therapies Inc. of misleading consumers by issuing a press release touting purported clinical evidence that its bone disease drug is superior to Genzyme’s market-leading Cerezyme.

Genzyme is fighting back against a June 28 Shire release that purported to describe new data from a head-to-head clinical trial showing Shire’s VPRIV drug for the treatment of Gaucher-related bone disease improved lumbar spine density while Genzyme’s Cerezyme did not, saying the conclusions come...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.